Journal of Medicinal Chemistry · 2011 · 49 citations · 17 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoverySynthetic Medicinal ChemistryLead Compound DesignLigand BindingLigand-based DesignPotency OptimizationStructure-activity Relationship AnalysisAgonist ActivityFull Agonist EfficacyIndole ChemistryMedicinal Chemistry ApplicationsMelatonin PharmacologyMelatonin Receptor PharmacologyPharmacological ProfilingPharmacological Screening
A novel series of 1,6-dihydro-2H-indeno[5,4-b]furan derivatives were designed and synthesized as MT(2)-selective ligands. This scaffold was identified as a potent mimic of the 5-methoxy indole core of melatonin, and introduction of a cyclohexylmethyl group at the 7-position of this scaffold afforded an MT(2)-selective ligand 15 (K(i) = 0.012 nM) with high MT(1)/MT(2) selectivity (799). Compound 15 was identified as a potent full agonist for the MT(2) subtype and exhibited reentrainment effects to a new light/dark cycle in ICR mice at 3-30 mg/kg. This result demonstrated the involvement of the MT(2) receptors in chronobiotic activity.
17
Molecular Dissection of Two Distinct Actions of Melatonin on the Suprachiasmatic Circadian Clock
Chen Liu, David R. Weaver, Xiaowei Jin et al. · Neuron · 1997 · 719 citations · Full text
Identification of the Melatonin-binding SiteMT 3 as the Quinone Reductase 2
Olivier Nosjean, Myriam Ferro, Francis Cogé et al. · Journal of Biological Chemistry · 2000 · 596 citations · Full text
Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist
Koki Kato, Keisuke Hirai, Keiji Nishiyama et al. · Neuropharmacology · 2004 · 537 citations
M. L. Dubocovich, Monica I. Masana, Stanca Iacob et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 1997 · 329 citations · Full text